05/14/2025
7:59 AM | CNS Pharmaceuticals (Filer)
| Form 424B4 | |
05/13/2025
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
05/12/2025
5:03 AM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
04/09/2025
2:32 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:11 PM | CNS Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
4:12 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
4:17 PM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
03/20/2025
4:15 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
11:24 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:19 PM | CNS Pharmaceuticals (Filer)
| Form DEFR14A | |
Get the Latest News and Ratings for CNSP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/01/2024
8:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:15 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
10/24/2024
4:27 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
10:23 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
10/23/2024
7:02 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:24 PM | CNS Pharmaceuticals (Filer)
| Form PRE 14A | |
09/12/2024
7:58 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:22 PM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
4:11 PM | CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:53 PM | CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/04/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
07/31/2024
11:32 AM | CNS Pharmaceuticals (Filer)
| Form RW | |
07/30/2024
4:13 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:15 PM | CNS Pharmaceuticals (Filer)
| Form 424B3 | |
07/30/2024
6:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
7:30 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
07/26/2024
7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
8:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:12 PM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
Free CNSP Stock Alerts